Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
Sherwin-Williams
SHW
|
+$570M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
NXP Semiconductors
NXPI
|
+$346M |
| 5 |
International Flavors & Fragrances
IFF
|
+$334M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$222M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$186M |
| 3 |
Booking.com
BKNG
|
+$122M |
| 4 |
EV
Eaton Vance Corp.
EV
|
+$104M |
| 5 |
iShares MSCI Taiwan ETF
EWT
|
+$80.1M |
Sector Composition
| 1 | Technology | 23.28% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.2% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Solid Biosciences
SLDB
$408M
| $3M | ﹤0.01% |
36,210
+5,032
| +16% | +$417K |
|
3052
Forte Biosciences
FBRX
$135M
| $3M | ﹤0.01% |
3,502
+382
| +12% | +$327K |
|
|
BPYU
3053
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $3M | ﹤0.01% |
166,986
-4,038
| -2% | -$72.5K |
|
3054
Gold Resource Corp
GORO
$114M
| $2.99M | ﹤0.01% |
1,131,649
+102,205
| +10% | +$270K |
|
3055
Alto Ingredients
ALTO
$89M
| $2.98M | ﹤0.01% |
549,310
-287,018
| -34% | -$1.56M |
|
|
TLIS
3056
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $2.98M | ﹤0.01% |
+15,468
| New | +$2.98M |
|
3057
Aviat Networks
AVNW
$289M
| $2.98M | ﹤0.01% |
83,822
+18,354
| +28% | +$652K |
|
|
INZY
3058
DELISTED
Inozyme Pharma
INZY
| $2.98M | ﹤0.01% |
150,361
+43,915
| +41% | +$869K |
|
3059
Lineage Cell Therapeutics
LCTX
$276M
| $2.97M | ﹤0.01% |
1,265,951
+200,662
| +19% | +$471K |
|
3060
Comstock
LODE
$138M
| $2.97M | ﹤0.01% |
64,928
+57,515
| +776% | +$2.63M |
|
|
ALSK
3061
DELISTED
Alaska Communications Systems
ALSK
| $2.97M | ﹤0.01% |
914,676
+115,733
| +14% | +$376K |
|
|
OYST
3062
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $2.97M | ﹤0.01% |
162,402
+28,836
| +22% | +$527K |
|
|
MBII
3063
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $2.97M | ﹤0.01% |
1,419,121
+614,747
| +76% | +$1.28M |
|
3064
Mustang Bio
MBIO
$10.2M
| $2.96M | ﹤0.01% |
1,189
+146
| +14% | +$363K |
|
|
FUV
3065
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $2.96M | ﹤0.01% |
11,184
+1,185
| +12% | +$314K |
|
|
AFIB
3066
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $2.95M | ﹤0.01% |
220,949
+61,516
| +39% | +$822K |
|
|
CSPR
3067
DELISTED
Casper Sleep Inc.
CSPR
| $2.95M | ﹤0.01% |
407,975
+69,847
| +21% | +$506K |
|
3068
RELX
RELX
$84.6B
| $2.95M | ﹤0.01% |
117,364
+35,175
| +43% | +$885K |
|
3069
First Bank
FRBA
$415M
| $2.95M | ﹤0.01% |
242,534
+15,746
| +7% | +$192K |
|
3070
Concrete Pumping Holdings
BBCP
$366M
| $2.95M | ﹤0.01% |
398,218
-18,376
| -4% | -$136K |
|
3071
HDFC Bank
HDB
$180B
| $2.95M | ﹤0.01% |
37,944
-2,072
| -5% | -$161K |
|
|
CGC
3072
Canopy Growth
CGC
$434M
| $2.94M | ﹤0.01% |
9,398
+1,092
| +13% | +$342K |
|
3073
Viemed Healthcare
VMD
$256M
| $2.94M | ﹤0.01% |
290,482
+27,733
| +11% | +$281K |
|
3074
Atlanticus Holdings
ATLC
$1.02B
| $2.94M | ﹤0.01% |
96,806
+7,361
| +8% | +$223K |
|
3075
Parke Bancorp
PKBK
$267M
| $2.93M | ﹤0.01% |
146,818
+3,964
| +3% | +$79.2K |
|